Live Breaking News & Updates on Biopharma development

Stay updated with breaking news from Biopharma development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

RRD International is now RRD Biopharma Development

RRD International is now RRD Biopharma Development
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China , Dublin , Ireland , Rockville , County-dun-laoghaire-rathdown , Scott-tarrant , Product-development-team , Biopharma-development , Rrd-biopharma-development , Uniphar-group ,

RRD International rebrands as RRD Biopharma Development - Maryland Daily Record

RRD International rebrands as RRD Biopharma Development - Maryland Daily Record
thedailyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailyrecord.com Daily Mail and Mail on Sunday newspapers.

Dublin , Ireland , Rockville , County-dun-laoghaire-rathdown , Biopharma-development , Product-development-team , Farm-road ,

'Game-changing' drug to treat hot flushes approved for UK use

'Game-changing' drug to treat hot flushes approved for UK use
itv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itv.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , United-states , America , Waljit-dhillo , Diane-danzebrink , Imperial-college-london , Healthcare-products-regulatory-agency , Drug-administration , National-institute-for-health , Head-of-biopharma-development

Astellas' Veoza™ (fezolinetant) approved by European Commission for treatment of Vasomotor Symptoms (VMS) associated with menopause

VMS, also known as hot flushes and/or night sweats, is a common symptom of menopause

Ireland , Canada , Rossella-nappi , Drug-administration , Astellas-pharma-co-ltd , Head-of-biopharma-development , Research-center , University-of-pavia , San-matteo-foundation , European-commission , Full-professor , Reproductive-medicine

Astellas secures EC approval for VMS treatment, fezolinetant

Astellas secures EC approval for VMS treatment, fezolinetant
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Canada , Liechtenstein , Switzerland , Norway , United-states , Iceland , Rossella-nappi , Astellas-pharma-veozatm , Drug-administration , Head-of-biopharma-development-at-astellas , European-commission , University-of-pavia

Astellas' VEOZATM (fezolinetant) Approved by European Commission for Treatment of Vasomotor Symptoms Associated with Menopause

Astellas' VEOZATM (fezolinetant) Approved by European Commission for Treatment of Vasomotor Symptoms Associated with Menopause
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Iceland , United-states , Norway , Tokyo , Japan , Canada , Liechtenstein , Naoki-okamura , Rossella-nappi , Przegl-menopauzalny , J-public-health , Health-qual-life-outcomes

Astellas' VEOZAtm (fezolinetant) Approved by European Commission for Treatment of Vasomotor Symptoms Associated with Menopause

Astellas' VEOZAtm (fezolinetant) Approved by European Commission for Treatment of Vasomotor Symptoms Associated with Menopause
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states , Liechtenstein , Canada , Iceland , Norway , Tokyo , Japan , Przegl-menopauzalny , Naoki-okamura , Astella-veozatm , Rossella-nappi , European-commission

Astellas' VEOZA™ (fezolinetant) Approved by European Commission for Treatment of Vasomotor Symptoms Associated with Menopause

First-in-class treatment option reduces number and intensity of hot flashes and night sweats
TOKYO, Dec. 10, 2023 /PRNewswire/ -- Astellas Pharma Inc. today announced the European Commission on...

United-states , Norway , Liechtenstein , Iceland , Tokyo , Japan , Canada , Przegl-menopauzalny , Naoki-okamura , Rossella-nappi , Committee-for-medicinal-products-human-use , J-public-health

Astellas Pharma's treatment for hot flashes and sweats approved

A treatment option to reduce the number and intensity of hot flashes and night sweats associated with menopause has been approved by the European Commission (EC).

Canada , Iceland , Norway , Liechtenstein , Rossella-nappi , European-union , University-of-pavia , European-union-eu-member-states , Astellas-pharma-inc , Biopharma-development-at-astellas , Research-center , San-matteo-foundation

Astellas' Fezolinetant Reduces Frequency and Severity of VMS Associated with Menopause in Women Considered Unsuitable for Hormone Therapy

Phase 3b DAYLIGHT study being presented at ESG 2023 demonstrated fezolinetant 45 mg achieved statistically significant reductions in the frequency and severity of moderate to severe vasomotor symptoms due to menopause and patient-reported sleep disturbance at 24 weeks Women considered unsuitable included those with contraindications, who are averse to taking, have stopped taking or have conditions that suggest caution in using hormone therapy Results will support health technology a...

Tokyo , Japan , Netherlands , Turkey , Amsterdam , Noord-holland , Canada , Rossella-nappi , Naoki-okamura , San-matteo-foundation , University-of-pavia , European-society-of-gynecology